As of January 22, 2025, Cytek Biosciences (CTKB) has a market cap of $0.74 billion USD. According to our data, Cytek Biosciences is ranked No.5610 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.74 B |
-11.09%
|
Dec 31, 2024 | $0.84 B |
-28.84%
|
Dec 29, 2023 | $1.17 B |
-10.68%
|
Dec 30, 2022 | $1.32 B |
-37.44%
|
Dec 31, 2021 | $2.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Park Hotels & Resorts
PK
|
$2.83 B |
0.000 M
|
USA
|
Merck KGaA
MRK.DE
|
$65.46 B |
46.002 B
|
Germany
|
Sartorius
SRT.DE
|
$16.31 B |
9.230 B
|
Germany
|
Sysmex
6869.T
|
$11.85 B |
0.102 B
|
Japan
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
Market Cap | = | CTKB Stock Price | * | CTKB Shares Outstanding |
= | $5.77 | * | 0.13 B | |
= | $0.74 B |